We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Depression Confirmed as Osteoporosis Risk Factor

By LabMedica International staff writers
Posted on 22 Nov 2009
A recently published review article summarized studies relating clinical depression and osteoporosis and concluded that a clear connection exists between the two.

Osteoporosis is the most widespread degenerative disease in the developed world, afflicting about 33% of women and 20% of men in the over 50 age group. More...
In an endeavor to better understand risk factors for the syndrome, investigators at the Hebrew University of Jerusalem (Israel) reviewed research articles that related loss of bone mass, which characterizes osteoporosis, to evidence of clinical depression.

Their findings, based on the evaluation of 23 research projects conducted in eight countries that compared bone density among 2,327 people suffering from depression against 21,141 nondepressed individuals were published in the September 2009 issue of the journal Biological Psychiatry. The results showed that overall, depressed individuals displayed lower bone mass density than nondepressed subjects. The association between depression and bone mass density was similar in the spine, hip, and forearm. It was stronger in women than in men, and in premenopausal than postmenopausal women. Only women individually diagnosed for major depression by a psychiatrist displayed significantly lower bone mass density; women diagnosed by self-rating questionnaires did not. Depressed subjects had increased urinary levels of bone breakdown markers as compared to their nondepressed counterparts.

Based on these findings the authors concluded that, "All individuals psychiatrically diagnosed with major depression are at risk for developing osteoporosis, with depressed young women showing the highest risk. These patients should be periodically evaluated for progression of bone loss and signs of osteoporosis, allowing the use of antiosteoporotic prophylactic and therapeutic treatments."

Related Links:
Hebrew University of Jerusalem




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Clinical Informatics Platform
CLARION™
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.